We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLR icon
251
Digital Realty Trust
DLR
$73.7B
$2.96M 0.04%
25,949
+280
+1% +$33K
AWK icon
252
American Water Works
AWK
$26.3B
$2.9M 0.04%
31,750
+3,005
+10% +$266K
CNI icon
253
Canadian National Railway
CNI
$78.3B
$2.9M 0.04%
35,200
-2,050
-6% -$165K
ABT icon
254
Abbott
ABT
$180B
$2.82M 0.04%
49,442
-738
-1% -$40.9K
BF.B icon
255
Brown-Forman Class B
BF.B
$12B
$2.8M 0.04%
63,758
+1,344
+2% +$51.3K
EQNR icon
256
Equinor
EQNR
$95.9B
$2.75M 0.04%
128,300
– –
ROP icon
257
Roper Technologies
ROP
$36.3B
$2.75M 0.04%
10,611
-50
-0.5% -$12.8K
AMGN icon
258
Amgen
AMGN
$203B
$2.73M 0.04%
15,723
– –
ORLY icon
259
O'Reilly Automotive
ORLY
$72.4B
$2.67M 0.04%
166,350
-16,275
-9% -$242K
GE icon
260
GE Aerospace
GE
$367B
$2.63M 0.04%
31,456
-599
-2% -$57.2K
ABBV icon
261
AbbVie
ABBV
$458B
$2.58M 0.04%
26,712
+750
+3% +$70.7K
FTI icon
262
TechnipFMC
FTI
$30.6B
$2.58M 0.04%
110,537
-1,915
-2% -$39.6K
DOV icon
263
Dover
DOV
$27.2B
$2.57M 0.04%
31,489
+3,634
+13% +$281K
VRSK icon
264
Verisk Analytics
VRSK
$26.4B
$2.56M 0.04%
+26,610
New +$2.41M
HST icon
265
Host Hotels & Resorts
HST
$16.8B
$2.51M 0.04%
126,635
+26,560
+27% +$521K
FISV
266
Fiserv Inc
FISV
$27.2B
$2.48M 0.04%
37,840
+2,900
+8% +$187K
HAS icon
267
Hasbro
HAS
$12.6B
$2.47M 0.04%
27,164
-1,900
-7% -$178K
EXPE icon
268
Expedia Group
EXPE
$31.2B
$2.38M 0.03%
+19,870
New +$2.58M
CLX icon
269
Clorox
CLX
$11.6B
$2.36M 0.03%
15,875
-175
-1% -$23.8K
KO icon
270
Coca-Cola
KO
$354B
$2.29M 0.03%
50,020
-582
-1% -$26.8K
BF.A icon
271
Brown-Forman Class A
BF.A
$12.3B
$2.18M 0.03%
40,500
– –
NOV icon
272
NOV
NOV
$7.45B
$2.05M 0.03%
56,948
-3,349
-6% -$113K
BALL icon
273
Ball Corp
BALL
$17B
$2.04M 0.03%
53,765
+275
+0.5% +$11.2K
ABB
274
DELISTED
ABB Ltd
ABB
$2.04M 0.03%
75,892
-20,000
-21% -$514K
RTX icon
275
RTX Corp
RTX
$287B
$1.99M 0.03%
24,766
-254
-1% -$19.3K
9 10
11
12 13

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.